DaVita (NYSE:DVA) Hits New 1-Year High – Here’s What Happened

DaVita Inc. (NYSE:DVA) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as $240.07 and last traded at $240.1660, with a volume of 46619 shares changing hands. The stock had previously closed at $236.31.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. UBS Group raised their price objective on DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a report on Friday, July 10th. TD Cowen boosted their price target on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Truist Financial boosted their target price on shares of DaVita from $205.00 to $250.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of DaVita in a report on Monday, June 8th. Finally, Zacks Research cut DaVita from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Two investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $216.50.

DaVita Stock Performance

The stock has a market capitalization of $15.45 billion, a price-to-earnings ratio of 22.32, a PEG ratio of 0.78 and a beta of 0.88. The company has a 50 day moving average of $216.12 and a 200 day moving average of $171.76.

DaVita (NYSE:DVA) last issued its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. During the same quarter last year, the company earned $2.00 earnings per share. The firm’s revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts expect that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insider Transactions at DaVita

In related news, CFO Joel Ackerman sold 51,471 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. This represents a 27.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the transaction, the insider owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Root Financial Partners LLC raised its stake in shares of DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after purchasing an additional 105 shares during the last quarter. Caitlin John LLC purchased a new position in DaVita in the 4th quarter valued at $34,000. Sankala Group LLC acquired a new position in DaVita in the 4th quarter valued at $39,000. Canada Pension Plan Investment Board purchased a new position in DaVita during the 2nd quarter worth $43,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of DaVita in the 4th quarter worth $45,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.